Regulation of the cytoskeleton: an oncogenic function for cdk inhibitors? (original) (raw)
Sherr, C. J. & McCormick, F. The Rb and p53 pathways in cancer. Cancer Cell2, 103–112 (2002). CASPubMed Google Scholar
Ridley, A. J. et al. Cell migration: integrating signals from front to back. Science302, 1704–1709 (2003). CASPubMed Google Scholar
Sherr, C. J. & Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev.13, 1501–1512 (2001). Google Scholar
Polyak, K. et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell78, 59–66 (1994). CASPubMed Google Scholar
Russo, A., Jeffrey, P., Patten, A., Massague, J. & Pavletich, N. Crystal structure of the p27Kip1 cyclin dependent kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature382, 325–331 (1996). CASPubMed Google Scholar
Fero, M. L. et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27_Kip1_-deficient mice. Cell85, 733–744 (1996). CASPubMed Google Scholar
Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M. & Kemp, C. J. The murine gene p27_Kip1_ is haplo-insufficient for tumour suppression. Nature396, 177–180 (1998). CASPubMedPubMed Central Google Scholar
Bloom, J. & Pagano, M. Deregulated degradation of the CDK inhibitor p27 and malignant transformation. Semin. Cancer Biol.13, 41–47 (2003). CASPubMed Google Scholar
Slingerland, J. & Pagano, M. Regulation of the CDK inhibitor p27 and its deregulation in cancer. J. Cell. Physiol.183, 10–17 (2000). CASPubMed Google Scholar
Philipp-Staheli, J., Payne, S. R. & Kemp, C. J. p27Kip1: regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp. Cell Res.264, 148–168 (2001). CASPubMed Google Scholar
Ponce-Castaneda, M. et al. p27Kip1: chromosomal mapping to 12p12–12p13.1 and absence of mutations in human tumors. Cancer Res.55, 1211–1214 (1995). CASPubMed Google Scholar
Liang, J. et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nature Med.8, 1153–1160 (2002). CASPubMed Google Scholar
Anayama, T., Furihata, M., Ishikawa, T., Ohtsuki, Y. & Ogoshi, S. Positive correlation between p27Kip1 expression and progression in human esophageal squamous cell carcinoma. Int. J. Cancer79, 439–443 (1998). CASPubMed Google Scholar
Dellas, A., Schultheiss, E., Leivas, M. R., Moch, H. & Torhorst, J. Association of p27Kip1, cyclin E and _c_-myc expression with progression and prognosis in HPV-positive cervical neoplasms. Anticancer Res.18, 3991–3998 (1998). CASPubMed Google Scholar
Vrhovac, R. et al. Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia. Blood91, 4694–4700 (1998). CASPubMed Google Scholar
Saez, A. et al. p27Kip1 is abnormally expressed in diffuse large B-cell lymphomas and is associated with an adverse clinical outcome. Br. J. Cancer80, 1427–1434 (1999). CASPubMedPubMed Central Google Scholar
Sanchez-Beato, M. et al. Anomalous high p27Kip1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27Kip1-cyclin D3 colocalization in tumor cells. Blood94, 765–772 (1999). CASPubMed Google Scholar
Shiozawa, T. et al. Expression of the cell cycle regulator p27Kip1 in normal squamous epithelium, cervical intraepithelial neoplasia, and invasive squamous cell carcinoma of the uterine cervix. Cancer92, 3005–3011 (2001). CASPubMed Google Scholar
Kouvaraki, M. et al. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas. Cancer94, 2454–2465 (2002). CASPubMed Google Scholar
Watanabe, J. et al. Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinomas of the uterine corpus with proliferation and clinicopathological parameters. Br. J. Cancer87, 81–85 (2002). CASPubMedPubMed Central Google Scholar
McAllister, S. S., Becker-Hapak, M., Pintucci, G., Pagano, M. & Dowdy, S. Novel p27kip1 C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mol. Cell. Biol.23, 216–228 (2003). Overexpression of p27 induces cell scattering, independently of its ability to bind the cyclin–CDK complex. Hepatocyte growth factor (HGF) stimulation induced p27 phosphorylation on Ser10 and its cytoplasmic translocation, which was required for cell scattering. CASPubMedPubMed Central Google Scholar
Blangy, A. et al. Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo. Cell83, 1159–1169 (1995). CASPubMed Google Scholar
Ubersax, J. et al. Targets of the cyclin-dependent kinase Cdk1. Nature425, 859–864 (2003). CASPubMed Google Scholar
Yamashiro, S., Yamakita, Y., Hosoya, H. & Matsumura, F. Phosphorylation of non-muscle caldesmon by p34cdc2 kinase during mitosis. Nature349, 169–172 (1991). CASPubMed Google Scholar
Swanton, C. Cell-cycle targeted therapies. Lancet Oncol5, 27–36 (2004). CASPubMed Google Scholar
Roninson, I. Oncogenic functions of tumour suppressor p21Waf1/Cip1/Sdi1: association with cell senescence and tumour promoting activities of stromal fibroblasts. Cancer Lett.179, 1–14 (2002). CASPubMed Google Scholar
Burridge, K. & Wennerberg, K. Rho and Rac take the center stage. Cell116, 167–179 (2004). CASPubMed Google Scholar
Etienne-Manneville, S. & Hall, A. Rho GTPases in cell biology. Nature420, 629–635 (2002). CASPubMed Google Scholar
Zohn, I. M., Campbell, S. L., Khosravi-Far, R., Rossman, K. L. & Der, C. J. Rho family proteins and Ras transformation: the RHOad less traveled gets congested. Oncogene17, 1415–1438 (1998). CASPubMed Google Scholar
Ridley, A. J. Rho proteins and cancer. Breast Cancer Res. Treat.84, 13–19 (2004). CASPubMed Google Scholar
Roovers, K. & Assoian, R. K. Effects of rho kinase and actin stress fibers on sustained extracellular signal-regulated kinase activity and activation of G1 phase cyclin-dependent kinases. Mol. Cell. Biol.23, 4283–4294 (2003). CASPubMedPubMed Central Google Scholar
Welsh, C. F. & Assoian, R. K. A growing role for Rho family GTPases as intermediaries in growth factor- and adhesion-dependent cell cycle progression. Biochim. Biophys. Acta1471, M21–29 (2000). CASPubMed Google Scholar
Roovers, K. & Assoian, R. K. Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays22, 818–826 (2000). CASPubMed Google Scholar
Mettouchi, A. et al. Integrin-specific activation of Rac controls progression through the G1 phase of the cell cycle. Mol. Cell8, 115–127 (2001). CASPubMed Google Scholar
Roovers, K., Klein, E. A., Castagnino, P. & Assoian, R. K. Nuclear translocation of LIM kinase mediates Rho-Rho kinase regulation of cyclin D1 expression. Dev. Cell5, 273–84 (2003). The expression of cyclin D1 during the G1 phase of the cell cycle is promoted by Rac and antagonized by Rho–ROCK–LIMK signalling, thereby controlling the duration of the G1 phase. The inhibition of cyclin D1 expression requires the nuclear translocation of LIMK. CASPubMed Google Scholar
Sahai, E., Olson, M. F. & Marshall, C. J. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J.20, 755–766 (2001). Ras-transformed cells have elevated RhoA activity, which inhibits p21 expression. Ras-induced ERK activation downregulates Rho kinases, thereby uncoupling Rho signalling from stress-fibre formation, which results in increased Ras-transformed cell motility. CASPubMedPubMed Central Google Scholar
Olson, M. F., Paterson, H. F. & Marshall, C. J. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature394, 295–299 (1998). CASPubMed Google Scholar
Coleman, M. L., Marshall, C. J. & Olson, M. F. Ras promotes p21Waf1/Cip1 protein stability via a cyclin D1-imposed block in proteasome-mediated degradation. EMBO J.22, 2036–2046 (2003). CASPubMedPubMed Central Google Scholar
Vidal, A., Millard, S. S., Miller, J. P. & Koff, A. Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status. J. Biol. Chem.277, 16433–16440 (2002). CASPubMed Google Scholar
Hara, T., Kamura, T., Nakayama, K., Oshikawa, K. & Hatakeyama, S. Degradation of p27Kip1 at the G0-G1 transition mediated by a Skp2-independent ubiquitination pathway. J. Biol. Chem.276, 48937–48943 (2001). CASPubMed Google Scholar
Malek, N. P. et al. A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature413, 323–327 (2001). CASPubMed Google Scholar
Mammoto, A., Huang, S., Moore, K., Oh, P. & Ingber, D. Role of RhoA, mDia, and ROCK in cell shape-dependent control of the Skp2-p27Kip1 pathway and the G1/S transition. J. Biol. Chem.279, 26323–26330 (2004). CASPubMed Google Scholar
Sahai, E., Ishizaki, T., Narumiya, S. & Treisman, R. Transformation mediated by RhoA requires activity of ROCK kinases. Curr. Biol.9, 136–145 (1999). CASPubMed Google Scholar
Shimada, Y., Gulli, M. & Peter, M. Nuclear sequestration of the exchange factor Cdc24 by Far1 regulates cell polarity during yeast mating. Nature Cell Biol.2, 117–124 (2000). CASPubMed Google Scholar
Yokoo, T. et al. p57Kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus. J. Biol. Chem.278, 52919–52923 (2003). p57 interacts with LIMK1 independently of its ability to bind the cyclin–CDK complex. Overexpression of p57 results in the nuclear localization of LIMK1 and loss of actin stress fibres. CASPubMed Google Scholar
Tanaka, H. et al. Cytoplasmic p21Cip1/Waf1 regulates neurite remodeling by inhibiting Rho-kinase activity. J. Cell Biol.158, 321–329 (2002). Ectopic expression of p21 in the cytoplasm promotes neurite outgrowth and branching of hippocampal neurons and neuroblastoma cells. p21 directly binds to and inhibits Rho kinase, thereby preventing Rho–ROCK signalling induced growth cone collapse. CASPubMedPubMed Central Google Scholar
Lee, S. & Helfman, D. M. Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/Cofilin pathway. J. Biol. Chem.279, 1885–1891 (2003). Activated Ras-induced loss of actin stress fibres requires p21. p21 inhibits Rho kinase, thereby uncoupling Rho signalling from stress-fibre formation. PubMed Google Scholar
Zhou, B. et al. Cytoplasmic localization of p21Cip1/Waf1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nature Cell Biol.3, 245–252 (2001). CASPubMed Google Scholar
Besson, A., Gurian-West, M., Schmidt, A., Hall, A. & Roberts, J. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev.18, 862–876 (2004). Loss of p27 results in decreased migratory ability, owing to elevated Rho–ROCK signalling. p27 binds to RhoA to prevent the interaction of RhoA with GTP exchange factors and thereby RhoA activation. CASPubMedPubMed Central Google Scholar
Diez-Juan, A. & Andres, V. Coordinate control of proliferation and migration by the p27Kip1/cyclin-dependent kinase/Retinoblastoma pathway in vascular smooth muscle cells and fibroblasts. Circ. Res.92, 402–410 (2003). CASPubMed Google Scholar
Sahai, E. & Marshall, C. J. Differing modes of tumor cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nature Cell Biol.5, 711–719 (2003). Two modes of tumour cell invasion are identified: a rounded cell migration requires Rho–ROCK signalling and is independent of pericellular proteolysis. By contrast, an elongated mode of migration is dependent on Rac activity, is antagonized by Rho–ROCK signalling and requires pericellular proteolytic activity. CASPubMed Google Scholar
Tsuji, T. et al. ROCK and mDia1 antagonize in Rho-dependent Rac activation in Swiss 3T3 fibroblasts. J. Cell Biol.157, 819–830 (2002). CASPubMedPubMed Central Google Scholar
Boehm, M. et al. A growth factor-dependent nuclear kinase phosphorylates p27Kip1 and regulates cell cycle progression. EMBO J.21, 3390–3401 (2002). CASPubMedPubMed Central Google Scholar
Fujita, N., Sato, S., Katayama, K. & Tsuruo, T. Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J. Biol. Chem.277, 28706–28713 (2002). CASPubMed Google Scholar
Fahraeus, R. & Lane, D. The p16Ink4a tumor suppressor protein inhibits αvβ3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of αvβ3 to focal contacts. EMBO J.18, 2106–2118 (1999). CASPubMedPubMed Central Google Scholar
Manes, T. et al. αvβ3 integrin expression up-regulates cdc2, which modulates cell migration. J. Cell Biol.161, 817–826 (2003). CASPubMedPubMed Central Google Scholar
Neumeister, P. et al. Cyclin D1 governs adhesion and motility of macrophages. Mol. Biol. Cell14, 2005–2015 (2003). CASPubMedPubMed Central Google Scholar
Dirks, P., Hubbard, S., Murakami, M. & Rutka, J. Cyclin and cyclin-dependent kinase expression in human astrocytoma cell lines. J. Neuropathol. Exp. Neurol.56, 291–300 (1997). CASPubMed Google Scholar
Ito, Y. et al. Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma. Oncology59, 68–74 (2000). CASPubMed Google Scholar
Kallakury, B. et al. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma. Cancer80, 753–763 (1997). CASPubMed Google Scholar
Palazzo, A., Cook, T., Alberts, A. & Gundersen, G. mDia mediates Rho-regulated formation and orientation of stable microtubules. Nature Cell Biol.3, 723–729 (2001). CASPubMed Google Scholar
Ishizaki, T. et al. Coordination of microtubules and the actin cytoskeleton by the Rho effector mDia1. Nature Cell Biol.3, 8–14 (2001). CASPubMed Google Scholar